Linden Capital Partners, a Chicago-based healthcare private equity firm, announced the completion of the fundraise for its sixth buyout fund, Linden Capital Partners VI, with $5.2 billion of LP commitments and a $200 million GP commitment.
Passing its $4.5 billion target and initial $5 billion hard cap, Fund VI was substantially oversubscribed and represents a milestone achievement for the firm, following the close of Fund V in 2021 at $3.0 billion of LP commitments. And Linden is the largest dedicated healthcare private equity manager.
Linden’s growth has been driven by strategic investments in talent and resources. Now with a team of over 60 professionals, the firm also announced the final close of its second structured capital fund (SCF II) at $400 million earlier this month.
Advisors: Kirkland & Ellis served as fund counsel, and PJT Park Hill and Magenta Capital Services served as placement advisors.
KEY QUOTES:
“Fund VI is a defining accomplishment for Linden. Through the successful raise of our largest fund to date, we are excited to play an even more impactful role in shaping the future of healthcare and look forward to continuing to drive strong outcomes for our investors, management teams, and healthcare stakeholders. In a difficult fundraising market, the scale of Fund VI, the pace of the raise at just under nine months, and the expansion of our investor base reflect the confidence investors have in our firm, and we are grateful for that support.”
– Tony Davis, Linden Co-Founder and President
“It’s incredibly rewarding to see our franchise recognized and supported by such a broad and global group of partners, with over 20 countries represented in our investor base. We are deeply thankful for the trust of long-standing existing investors as well as strategic new investors, whose partnership makes this milestone possible.”
– Katie Kornel, Linden’s Investor Relations Partner
